Patent details

EP3074011 Title: OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS

  • Data
  • Documents

Basic Information

Publication number:
EP3074011
PCT Application Number:
US2014066759
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP148635147
PCT Publication Number:
WO2015077530
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
French Title of Invention:
MODULATEURS DE RECEPTEURS DE GLUCOCORTICOIDE AZADECALINE FUSIONNEE OCTAHYDRO
German Title of Invention:
OKTAHYDRO-KONDENSIERTE AZADECALINGLUCOCORTICOIDREZEPTORMODULATOREN
SPC Number:

Dates

Filing date:
21/11/2014
Grant date:
24/07/2019
EP Publication Date:
05/10/2016
PCT Publication Date:
28/05/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2019
EP B1 Publication Date:
24/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/11/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2019
 
 

Name:
Corcept Therapeutics Incorporated
Address:
149 Commonwealth Drive, Menlo Park, CA 94025, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
28/08/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WALTERS, Iain
Address:
United Kingdom (GB)

2

Name:
HUNT, Hazel
Address:
United Kingdom (GB)

3

Name:
GOURDET, Benoit
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201361908333 P
Priority Date:
25/11/2013
Priority Country:
United States (US)

2

Priority Number:
201461985035 P
Priority Date:
28/04/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4162; A61K 31/4375; C07D 471/04; C07D 498/04;

Publication

European Patent Bulletin

Issue number:
201930
Publication date:
24/07/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2024
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
CPA GLOBAL THE IP PLATFORM